ISPOR Undertakes Competencies Initiative for the Field of Health Economics and Outcomes Research

ISPOR HEOR Competencies Framework Will Focus on Key Competencies Necessary for Professionals in the Field

 

Princeton, NJ—September 19, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced a new initiative today that is focused on the competencies necessary for professionals working in the field of health economics and outcomes research (HEOR)—the ISPOR Health Economics and Outcomes Research Competencies Framework. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: ,

Plenary Sessions and Speakers Announced for ISPOR 20th Annual European Congress

Conference to Explore The Evolution of Value in Health Care on 4-8 November 2017 in Glasgow, Scotland


Princeton, NJ
—September 18, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced plenary sessions and speakers for its 20th Annual European Congress that will be held 4-8 November 2017 in Glasgow, Scotland, UK. The congress will center on the theme, “The Evolution of Value in Health Care.”  Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

The Voice of the Patient in Latin America

São Paulo. Brazil—17 September 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held its second plenary session, The Voice of the Patient, at its 6th Latin America Conference today focusing on how countries in the region can better incorporate the patient voice in the health care decision-making process. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , ,

Latin America Faces Opportunities and Challenges in the Goal to Achieve Universal Health Care Coverage

São Paulo, Brazil—16 September 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a plenary session at its 6th Latin America Conference today exploring the challenges and opportunities inherent in the move many of the region’s countries are taking toward universal health care coverage. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: ,

Making Real-World Data Studies More Useful for Health Care Decision Making

Value in Health Publishes Reports From the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making


Princeton, NJ
—September 15, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of guidance documents that provide new recommendations for developing good procedural practices for conducting studies using real-world data. Published in the September 2017 issue of Value in Health, this special collection of Task Force reports includes papers from both ISPOR and the International Society for Pharmacoepidemiology (ISPE) as part of the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making. Read more ›

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , ,

ISPOR Latin America Conference to Focus on Improving Health Outcomes Through Stakeholder Engagement

Conference to be Held 15-17 September 2017 in São Paulo, Brazil


Princeton, NJ
—September 5, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the leading professional society for health economics and outcomes research (HEOR), announced confirmation of the scientific sessions for its upcoming 6th Latin America Conference scheduled for 15-17 September 2017 in São Paulo, Brazil. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , , , , ,

ISPOR/ISPE Announce Plans for “Summit on Real-World Evidence in Health Care Decision Making”

Scheduled for October 20, 2017 in Washington, DC, USA

Princeton, NJ—August 22, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the International Society for Pharmacoepidemiology (ISPE) announced their plans for a 1-day conference focused on real-world evidence. The “ISPOR/ISPE Summit on Real-World Evidence in Health Care Decision Making” is scheduled for October 20, 2017 in Washington, DC, USA. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , , , , ,

ISPOR Leaders Named PharmaVOICE 100 Honorees

Immediate Past-President Professor Lou Garrison and CEO Nancy Berg Recognized as Inspirational Leaders in the Life Sciences


Princeton, NJ
—August 2, 2017—Two leaders of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) have been named to the renowned list of 2017 PharmaVOICE 100 honorees. Immediate Past-President Lou Garrison, PhD and Chief Executive Officer and Executive Director Nancy S. Berg have been named 2017 PharmaVOICE 100 honorees by PharmaVOICE magazine. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with:

Randomized Clinical Trials Shown to Accurately Predict Real-World Overall Survival

New Study Compares Clinical Trial Efficacy and Real-World Effectiveness of Therapies for Breast, Colorectal, Lung, Ovarian, and Pancreatic Cancers


Princeton, NJ—July 26, 2017—Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), announced today the publication of new research examining the relationship between the efficacy of randomized controlled trials (RCTs) and real-world effectiveness for oncology treatments. The report of these findings, “Predicting Real-World Effectiveness of Cancer Therapies Using Overall Survival and Progression-Free Survival from Clinical Trials: Empirical Evidence for the ASCO Value Framework,” was published in the July/August 2017 issue. Read more ›

Posted in Announcements, ISPOR News & Press, Uncategorized Tagged with: ,

What Is Real-World Data?: A Review of Definitions

New Report Identifies Disparate Opinions on the Meaning of Real World Data


Princeton, NJ—July 26, 2017—Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), announced today the publication of new research that sheds light on health care stakeholders’ perceptions of what qualifies as “real-world data.” The report of these findings, “What Is Real-World Data?: A Review of Definitions Based on Literature and Stakeholder Interviews,” was published in the July/August 2017 issue. Read more ›

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health